Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Holzgrefe

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Pharmacological and Toxicological Methods|July 11, 2015
CiPA: Ongoing testing, future qualification procedures, and pending issuesIcilio Cavero, Henry Holzgrefe
Advances in Physiology Education|August 4, 2022
Remembering the canonical discoverers of the core components of the mammalian cardiac conduction system: Keith and Flack, Aschoff and Tawara, His, and PurkinjeIcilio Cavero, Henry Holzgrefe
Journal of Pharmacological and Toxicological Methods|August 27, 2015
14th Annual Meeting of the Safety Pharmacology Society: Threading through peripheral and central nervous system presentationsIcilio Cavero, Henry Holzgrefe
Advances in Physiology Education|September 7, 2023
Internodal conduction pathways: revisiting a century-long debate on their existence, morphology, and location in the context of 2023 best scienceIcilio Cavero, Henry Holzgrefe
Expert Opinion on Drug Safety|May 22, 2014
Comprehensive in vitro Proarrhythmia Assay, a novel in vitro/in silico paradigm to detect ventricular proarrhythmic liability: a visionary 21st century initiativeIcilio Cavero, Henry Holzgrefe
Journal of Pharmacological and Toxicological Methods|September 24, 2016
15<sup>th</sup> Annual Meeting of the Safety Pharmacology Society: Focus on traditional sensory systemsIcilio Cavero, Henry Holzgrefe
Journal of Pharmacological and Toxicological Methods|February 24, 2016
The prospective IQ-CSRC trial: A prototype early clinical proarrhythmia assessment investigation for replacing the ICH E14 thorough QTc (TQT) studyIcilio Cavero, Henry Holzgrefe, Mike Clements
Journal of Pharmacological and Toxicological Methods|March 18, 2022
Nonclinical cardiovascular safety assessment of thioridazine: Impact of autonomic tone, body temperature, and choice of speciesAndrea Greiter-Wilke, Sonia Roberts, Katja Heinig, et al.
Journal of Pharmacological and Toxicological Methods|May 29, 2016
Comprehensive in vitro Proarrhythmia Assay (CiPA): Pending issues for successful validation and implementationIcilio Cavero, Jean-Michel Guillon, Veronique Ballet, et al.
Journal of Pharmacological and Toxicological Methods|May 22, 2013
Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortiumHenry Holzgrefe, Georg Ferber, Pascal Champeroux, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Pharmacological and Toxicological Methods|July 11, 2015
CiPA: Ongoing testing, future qualification procedures, and pending issuesIcilio Cavero, Henry Holzgrefe
Advances in Physiology Education|August 4, 2022
Remembering the canonical discoverers of the core components of the mammalian cardiac conduction system: Keith and Flack, Aschoff and Tawara, His, and PurkinjeIcilio Cavero, Henry Holzgrefe
Journal of Pharmacological and Toxicological Methods|August 27, 2015
14th Annual Meeting of the Safety Pharmacology Society: Threading through peripheral and central nervous system presentationsIcilio Cavero, Henry Holzgrefe
Advances in Physiology Education|September 7, 2023
Internodal conduction pathways: revisiting a century-long debate on their existence, morphology, and location in the context of 2023 best scienceIcilio Cavero, Henry Holzgrefe
Expert Opinion on Drug Safety|May 22, 2014
Comprehensive in vitro Proarrhythmia Assay, a novel in vitro/in silico paradigm to detect ventricular proarrhythmic liability: a visionary 21st century initiativeIcilio Cavero, Henry Holzgrefe
Journal of Pharmacological and Toxicological Methods|September 24, 2016
15<sup>th</sup> Annual Meeting of the Safety Pharmacology Society: Focus on traditional sensory systemsIcilio Cavero, Henry Holzgrefe
Journal of Pharmacological and Toxicological Methods|February 24, 2016
The prospective IQ-CSRC trial: A prototype early clinical proarrhythmia assessment investigation for replacing the ICH E14 thorough QTc (TQT) studyIcilio Cavero, Henry Holzgrefe, Mike Clements
Journal of Pharmacological and Toxicological Methods|March 18, 2022
Nonclinical cardiovascular safety assessment of thioridazine: Impact of autonomic tone, body temperature, and choice of speciesAndrea Greiter-Wilke, Sonia Roberts, Katja Heinig, et al.
Journal of Pharmacological and Toxicological Methods|May 29, 2016
Comprehensive in vitro Proarrhythmia Assay (CiPA): Pending issues for successful validation and implementationIcilio Cavero, Jean-Michel Guillon, Veronique Ballet, et al.
Journal of Pharmacological and Toxicological Methods|May 22, 2013
Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortiumHenry Holzgrefe, Georg Ferber, Pascal Champeroux, et al.
Pageof 2